A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Cancer
Related studies linked through entity extraction aliases.
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
- Status
- RECRUITING
- Phase
- PHASE3
Definitive Radiation for High-Risk Spine Metastases
- Status
- RECRUITING
- Phase
- PHASE2
FIH XON7 in Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Metastases Directed Therapy for Oligometastatic Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Disparities in Precision Oncology
- Status
- RECRUITING
- Phase
- N/A
Biomarkers to Detect Endocrine Therapy Resistance
- Status
- RECRUITING
- Phase
- PHASE2
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Trial of Written Exposure for Metastatic Cancer Patients (EASE)
- Status
- COMPLETED
- Phase
- NA
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Rurality Adapted Physical Activity Sport Health
- Status
- UNKNOWN
- Phase
- N/A
Study of OB-002 in Patients With Refractory Metastatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer
- Status
- RECRUITING
- Phase
- PHASE2